Unjha Formulations Limited

BSE: 531762
Unjha Formulations Limited - healthcare in Khali, Gujarat, India. FY 2026 financials and compliance.
CIN L99999GJ1994PLC022932 Incorporated 02 September 1994 ROC Ahmedabad HQ Khali, Gujarat, India
Active Listed - BSE: 531762 Public Limited Company healthcare
Data last updated
Revenue · FY 2026
₹15.59 Cr
▲ 12.43% YoY
Computed EBITDA · FY 2026
₹1.1 Cr
▲ 75.15% YoY
Net profit · FY 2026
₹70.47 Lakh
▲ 72.89% YoY
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹4.48 Cr
Issued & subscribed
Open charges
₹32 Lakh
Secured borrowings
Company age
32 yrs
Est. 1994
Employees · EPFO
12
Latest available

About Unjha Formulations Limited

Data last updated: 13 July 2026

Unjha Formulations Limited is a public limited company based in Khali, Gujarat, India. It specialises in ayurvedic products and services, a part of the broader healthcare sector. Incorporated on 02 September 1994, the company has been in operation for over 32 years.

Registered with ROC Ahmedabad under CIN L99999GJ1994PLC022932. Listed on BSE: 531762.

Capital: an authorised share capital of ₹10 Cr and a paid-up capital of ₹4.48 Cr. It is led by directors including Krutiben Mayankkumar Patel and Hasmukh Shivrambhai Darji.

Last AGM: 13 August 2025. Financial statements filed for year ended 31 March 2025. Office: Khali Char Rasta State Highway Tal – Sidhpur Patan, Gujarat, India – 384151.

As per BSE-filed standalone financials for FY 2026, the company reported a revenue of ₹15.59 Cr, a growth of 12.43% compared to the previous year. The net worth stands at ₹3.84 Cr (up 22.45% YoY). Total assets are valued at ₹5.51 Cr (up 20.93% YoY).

The company has a workforce of approximately 12 employees as per the latest available data.

The company is associated with 1 brand - Unjha Formulations. As per MCA filings, the company has open charges of ₹32 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website unjhaformulations.com.

Company Details of Unjha Formulations Limited
CIN L99999GJ1994PLC022932
Registration Number 022932
Incorporation Date 02 September 1994
ROC Ahmedabad
Listing Status Listed (BSE: 531762)
Company Status Active
Date of Last AGM 13 August 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Krutiben Mayankkumar Patel Managing Director Esha Mayank Patel Whole-Time Director Hasmukh Shivrambhai Darji Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    unjhaformulations.com
  • Social Media
  • Registered Address
    Khali Char Rasta State Highway Tal – Sidhpur Patan, Gujarat, India – 384151
  • Industry
    Healthcare, Ayurvedic Products & Services
Company report
Unjha Formulations Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Unjha Formulations Limited report

Financials, compliance, directors, charges, ownership and filings for Unjha Formulations Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Unjha Formulations Limited

Unjha Formulations Limited operates one associated brand: Unjha Formulations. These brands represent Unjha Formulations Limited's diversified market presence and brand portfolio.

Brand Description Website
Unjha Formulations
Contract manufacturing of ayurvedic formulations is conducted by Unjha Formulations. unjhaformulations.com

Competitors & Alternatives of Unjha Formulations Limited

Brands and companies operating in the same space as Unjha Formulations Limited include Inventia Healthcare, Zim Labs, Lotus and 7 more.

Competitor Description Location Founded
Inventia Healthcare Inventia Healthcare Oral solid drug delivery systems are manufactured and developed. Mumbai, India, India 1985
Zim Labs Zim Labs Solid and semisolid dosage forms are developed and manufactured. Nagpur, India, India 1989
Lotus Lotus Contract manufacturing for oral solid formulations is offered. Taipei, Taiwan, Taiwan 1966
Contract Pharmacal Corp. Contract Pharmacal Corp. Product development, manufacturing and packaging services Hauppauge, United States, United States 1971
Adare Pharma Solutions Adare Pharma Solutions CDMO manufacturing solid drugs Lawrence Township, United States, United States 2015
Suzhou Ze Jing Biological Pharmaceutical Suzhou Ze Jing Biological Pharmaceutical Company developing small molecules & eukaryotic cell based recombinant protein drugs Suzhou, China, China 2009
Halewood Laboratories Halewood Laboratories Provides contract manufacturing services for food, pharmaceuticals, and related products globally. Ahmedabad, India, India 1984
Capsugel Capsugel Dosage forms are delivered for preclinical, clinical, and commercial supply. Morristown, United States, United States 1875
Glukem Glukem Manufactures pellets, micro-pellets, granules, and capsules for pharmaceutical and nutraceutical drugs. Hyderabad, India, India 2014
Vovantis Laboratories Vovantis Laboratories Develops and manufactures novel effervescent drug delivery systems. Vadodara, India, India 2008

Business Activity of Unjha Formulations Limited

Unjha Formulations Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Unjha Formulations Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Unjha Formulations Limited

Unjha Formulations Limited is audited by JAIN AND GOLECHA (ICAI peer reviewed, certificate valid till 2026-03-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
JAIN AND GOLECHA (ICAI peer reviewed, certificate valid till 2026-03-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Unjha Formulations Limited

Unjha Formulations Limited is currently managed by 6 directors, with 11 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Krutiben Mayankkumar Patel
Also directs: Urvesh Psyllium Industries Limited
Managing Director 01 Sep 2012 13 Years 10 Months Current
Hasmukh Shivrambhai Darji Director 21 May 2001 25 Years 1 Months Current
Mustufa Najmuddin Jodhpurwala Director 06 Feb 2021 5 Years 5 Months Current
Jitendrakumar Parshottamdas Limbachiya Director 08 Jan 2016 10 Years 6 Months Current
Jashodaben Shambhubhai Patel
Also directs: Urvesh Psyllium Industries Limited
Director 31 Jan 2014 12 Years 5 Months Current
Esha Mayank Patel Whole-Time Director 10 May 2023 3 Years 2 Months Current
View all directors

Financials of Unjha Formulations Limited FY 2026 filings available

Unjha Formulations Limited reported revenue of ₹15.59 Cr (up 12.43% YoY) for FY 2026.

Revenue · FY 2026
₹15.59 Cr ▲ 12.43%
Profit · FY 2026
₹70.47 Lakh ▲ 72.89%
Computed EBITDA · FY 2026
₹1.1 Cr ▲ 75.15%
Revenue₹ Cr · Standalone01020FY 2019: ₹11 Cr11.4FY 2019FY 2020: ₹11 Cr · -7.2% YoY10.6-7.2%FY 2020FY 2021: ₹10 Cr · -6.1% YoY10-6.1%FY 2021FY 2022: ₹14 Cr · +42.3% YoY14.2+42.3%FY 2022FY 2023: ₹13 Cr · -7.1% YoY13.2-7.1%FY 2023FY 2024: ₹18 Cr · +40.6% YoY18.5+40.6%FY 2024FY 2025: ₹14 Cr · -25.1% YoY13.9-25.1%FY 2025FY 2026: ₹16 Cr · +12.4% YoY15.6+12.4%FY 2026
Net Profit₹ Cr · Standalone00.30.50.8FY 2019: ₹0 Cr0.3FY 2019FY 2020: ₹0 Cr · +2.7% YoY0.3+2.7%FY 2020FY 2021: ₹0 Cr · -66.4% YoY0.1-66.4%FY 2021FY 2022: ₹0 Cr · +144% YoY0.3+144%FY 2022FY 2023: ₹0 Cr · +11.9% YoY0.3+11.9%FY 2023FY 2024: ₹0 Cr · -1.6% YoY0.3-1.6%FY 2024FY 2025: ₹0 Cr · +46.7% YoY0.4+46.7%FY 2025FY 2026: ₹1 Cr · +72.9% YoY0.7+72.9%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0246Q1'25: ₹4 Cr4Q1'25Q2'25: ₹4 Cr3.8Q2'25Q3'25: ₹4 Cr3.8Q3'25Q4'25: ₹2 Cr2.4Q4'25Q1'26: ₹4 Cr · -8.6% YoY3.6-8.6%Q1'26Q2'26: ₹4 Cr · +13.3% YoY4.3+13.3%Q2'26Q3'26: ₹4 Cr · +17.2% YoY4.4+17.2%Q3'26Q4'26: ₹3 Cr · +38.6% YoY3.3+38.6%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹15.59 Cr ₹13.86 Cr ₹18.5 Cr ₹13.15 Cr ₹14.16 Cr ₹9.96 Cr ₹10.6 Cr ₹11.42 Cr
Other Income ₹16.35 Lakh ₹11.47 Lakh ₹1.15 Lakh ₹3.07 Lakh ₹18.66 Lakh ₹21.67 Lakh ₹25.55 Lakh ₹10.19 Lakh
Total Income ₹15.75 Cr ₹13.98 Cr ₹18.51 Cr ₹13.18 Cr ₹14.35 Cr ₹10.17 Cr ₹10.86 Cr ₹11.52 Cr
Cost of Materials Consumed ₹12 Cr ₹11.32 Cr ₹15.55 Cr ₹10.49 Cr ₹11.47 Cr ₹7.55 Cr ₹8.2 Cr ₹8.76 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹3.7 Lakh ₹10.07 Lakh ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹94.21 Lakh ₹81.23 Lakh ₹58.82 Lakh ₹51.06 Lakh ₹57.84 Lakh ₹48.77 Lakh ₹45.74 Lakh ₹48.06 Lakh
Finance Costs ₹79,000 ₹81,000 ₹5.59 Lakh ₹5.79 Lakh ₹13.24 Lakh ₹17.25 Lakh ₹11.7 Lakh ₹2.09 Lakh
Depreciation & Amortisation ₹14.19 Lakh ₹9.84 Lakh ₹8.11 Lakh ₹7.65 Lakh ₹7.64 Lakh ₹8.12 Lakh ₹7.9 Lakh ₹8.62 Lakh
Other Expenses ₹1.66 Cr ₹1.11 Cr ₹1.78 Cr ₹1.72 Cr ₹1.8 Cr ₹1.77 Cr ₹1.69 Cr ₹1.88 Cr
Total Expenses ₹14.79 Cr ₹13.45 Cr ₹18.06 Cr ₹12.85 Cr ₹14.05 Cr ₹10.07 Cr ₹10.55 Cr ₹11.22 Cr
Profit Before Exceptional Items & Tax ₹95.38 Lakh ₹52.36 Lakh ₹45.18 Lakh ₹32.96 Lakh ₹29.96 Lakh ₹10.35 Lakh ₹30.83 Lakh ₹30.03 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹95.38 Lakh ₹52.36 Lakh ₹45.18 Lakh ₹32.96 Lakh ₹29.96 Lakh ₹10.35 Lakh ₹30.83 Lakh ₹30.03 Lakh
Total Tax Expense ₹24.91 Lakh ₹11.6 Lakh ₹17.39 Lakh ₹4.71 Lakh ₹4.71 Lakh ₹0 ₹0 ₹0
Net Profit ₹70.47 Lakh ₹40.76 Lakh ₹27.79 Lakh ₹28.25 Lakh ₹25.25 Lakh ₹10.35 Lakh ₹30.83 Lakh ₹30.03 Lakh
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income ₹70.47 Lakh ₹40.76 Lakh ₹27.79 Lakh ₹28.25 Lakh ₹25.25 Lakh ₹10.35 Lakh ₹30.83 Lakh ₹30.03 Lakh
EBITDA (computed) ₹1.1 Cr ₹63.01 Lakh ₹58.88 Lakh ₹46.4 Lakh ₹50.84 Lakh ₹35.72 Lakh ₹50.43 Lakh ₹40.74 Lakh
Basic EPS ₹1.57 ₹0.91 ₹0.62 ₹0.63 ₹0.56 ₹0.23 ₹0.69 ₹0.67
Diluted EPS ₹1.57 ₹0.91 ₹0.62 ₹0.63 ₹0.56 ₹0.23 ₹0.69 ₹0.67
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹5.51 Cr ₹4.56 Cr ₹4.93 Cr ₹3.41 Cr ₹3.44 Cr ₹3.53 Cr ₹3.72 Cr ₹3.65 Cr
Non-current Assets ₹1.3 Cr ₹1.2 Cr ₹1.12 Cr ₹1.1 Cr ₹1.07 Cr ₹1.12 Cr ₹1.14 Cr ₹1.12 Cr
Current Assets ₹4.21 Cr ₹3.35 Cr ₹3.81 Cr ₹2.31 Cr ₹2.37 Cr ₹2.4 Cr ₹2.57 Cr ₹2.54 Cr
Property, Plant & Equipment ₹79.52 Lakh ₹70.22 Lakh ₹62.1 Lakh ₹59.51 Lakh ₹56.98 Lakh ₹62.49 Lakh ₹64.11 Lakh ₹61.68 Lakh
Inventories ₹63.08 Lakh ₹1.03 Cr ₹1.26 Cr ₹1.14 Cr ₹1.07 Cr ₹1.15 Cr ₹48.36 Lakh ₹55 Lakh
Trade Receivables ₹1.35 Cr ₹1.51 Cr ₹1.61 Cr ₹1.05 Cr ₹69.63 Lakh ₹97.51 Lakh ₹1.15 Cr ₹1.34 Cr
Cash & Equivalents ₹1.64 Cr ₹64.38 Lakh ₹87.47 Lakh ₹1 Lakh ₹42.64 Lakh ₹17.12 Lakh ₹93.92 Lakh ₹65 Lakh
Equity (Net Worth) ₹3.84 Cr ₹3.14 Cr ₹2.73 Cr ₹2.45 Cr ₹2.17 Cr ₹1.92 Cr ₹1.81 Cr ₹1.51 Cr
Equity Share Capital ₹4.48 Cr ₹4.48 Cr ₹4.48 Cr ₹4.48 Cr ₹4.48 Cr ₹4.48 Cr ₹4.48 Cr ₹4.48 Cr
Borrowings (Non-current) ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Borrowings (Current) ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Debt (computed) ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Current Liabilities ₹35.61 Lakh ₹1.41 Cr ₹2.2 Cr ₹95.65 Lakh ₹1.26 Cr ₹0 ₹1.9 Cr ₹2.15 Cr
Total Liabilities ₹1.67 Cr ₹1.42 Cr ₹2.2 Cr ₹95.65 Lakh ₹1.26 Cr ₹1.61 Cr ₹1.9 Cr ₹2.15 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹1.24 Cr -₹4.49 Lakh ₹1.03 Cr -₹25.88 Lakh ₹39.2 Lakh
Investing Cash Flow -₹23.49 Lakh -₹17.79 Lakh -₹10.69 Lakh -₹9.97 Lakh -₹44,000
Financing Cash Flow -₹79,000 -₹81,000 -₹5.59 Lakh -₹5.79 Lakh -₹13.24 Lakh
Capital Expenditure ₹0 -₹30,000 ₹0 ₹0 ₹0
Free Cash Flow (computed) ₹1.24 Cr -₹4.79 Lakh ₹1.03 Cr -₹25.88 Lakh ₹39.2 Lakh
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash ₹1 Cr -₹23.09 Lakh ₹86.47 Lakh -₹41.64 Lakh ₹25.52 Lakh
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹3.28 Cr ₹4.41 Cr ₹4.29 Cr ₹3.61 Cr ₹2.37 Cr ₹3.76 Cr ₹3.78 Cr ₹3.95 Cr
Other Income ₹5.01 Lakh ₹3.13 Lakh ₹6.21 Lakh ₹1.99 Lakh ₹7.34 Lakh ₹1.14 Lakh ₹2.47 Lakh ₹22,000
Total Income ₹3.33 Cr ₹4.44 Cr ₹4.35 Cr ₹3.63 Cr ₹2.44 Cr ₹3.77 Cr ₹3.81 Cr ₹3.95 Cr
Cost of Materials Consumed ₹3.14 Cr ₹3.39 Cr ₹2.79 Cr ₹2.69 Cr ₹2.11 Cr ₹2.98 Cr ₹3.4 Cr ₹2.84 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹3.7 Lakh ₹0 ₹0 ₹0 ₹10.07 Lakh ₹0 ₹0 ₹0
Employee Benefit Expense ₹33.93 Lakh ₹32.09 Lakh ₹14.71 Lakh ₹13.48 Lakh ₹36.47 Lakh ₹19.63 Lakh ₹12.39 Lakh ₹17.86 Lakh
Finance Costs ₹29,000 ₹17,000 ₹14,000 ₹18,000 -₹8,000 ₹24,000 ₹25,000 ₹9,000
Depreciation & Amortisation ₹4.39 Lakh ₹4.09 Lakh ₹2.84 Lakh ₹2.86 Lakh ₹3.27 Lakh ₹2.29 Lakh ₹2.25 Lakh ₹2.21 Lakh
Other Expenses ₹26.33 Lakh ₹45.08 Lakh ₹56.5 Lakh ₹38.47 Lakh ₹12.3 Lakh ₹35.05 Lakh ₹37.03 Lakh ₹21.76 Lakh
Total Expenses ₹3.82 Cr ₹4.2 Cr ₹3.53 Cr ₹3.24 Cr ₹2.73 Cr ₹3.55 Cr ₹3.92 Cr ₹3.26 Cr
Profit Before Exceptional Items & Tax -₹49.37 Lakh ₹23.97 Lakh ₹81.78 Lakh ₹38.99 Lakh -₹29.04 Lakh ₹22.4 Lakh -₹11.06 Lakh ₹69.89 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax -₹49.37 Lakh ₹23.97 Lakh ₹81.78 Lakh ₹38.99 Lakh -₹29.04 Lakh ₹22.4 Lakh -₹11.06 Lakh ₹69.89 Lakh
Total Tax Expense ₹24.91 Lakh ₹0 ₹0 ₹0 ₹11.6 Lakh ₹0 ₹0 ₹0
Net Profit -₹74.28 Lakh ₹23.97 Lakh ₹81.78 Lakh ₹38.99 Lakh -₹40.64 Lakh ₹22.4 Lakh -₹11.06 Lakh ₹69.89 Lakh
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income -₹74.28 Lakh ₹23.97 Lakh ₹81.78 Lakh ₹38.99 Lakh -₹40.64 Lakh ₹22.4 Lakh -₹11.06 Lakh ₹69.89 Lakh
EBITDA (computed) -₹44.69 Lakh ₹28.23 Lakh ₹84.76 Lakh ₹42.03 Lakh -₹25.85 Lakh ₹24.93 Lakh -₹8.56 Lakh ₹72.19 Lakh
Basic EPS ₹-1.66 ₹0.53 ₹1.83 ₹0.90 ₹-0.91 ₹0.50 ₹-0.25 ₹1.56
Diluted EPS ₹-1.66 ₹0.53 ₹1.83 ₹0.90 ₹-0.91 ₹0.50 ₹-0.25 ₹1.56
Latest 8 quarters shown.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Unjha Formulations Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Unjha Formulations Limited

As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 36.92%, retail and other public shareholders hold 63.08% of Unjha Formulations Limited. The company had 4,235 shareholders on record.

Promoters: 36.92%Retail & Others: 63.08%
Mar 2026
QUARTER
36.92% Promoters
63.08% Retail & Others
Promoter holding - history
Now 36.92% · Mar 2026High 36.92% · Jun 2023Low 36.92% · Jun 2023
35%35.8%36.5%37.3%38%Jun 2023Dec 2023Jun 2024Dec 2024Jun 2025Dec 2025Jun 2023: 36.92%Sep 2023: 36.92%Dec 2023: 36.92%Mar 2024: 36.92%Jun 2024: 36.92%Sep 2024: 36.92%Dec 2024: 36.92%Mar 2025: 36.92%Jun 2025: 36.92%Sep 2025: 36.92%Dec 2025: 36.92%Mar 2026: 36.92%36.92%36.92%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters36.92%36.92%36.92%36.92%36.92%36.92%
Public63.08%63.08%63.08%63.08%63.08%63.08%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024
Promoters36.92%36.92%36.92%
Public63.08%63.08%63.08%
Promoter change (YoY, %pts)+0.00+0.00-

Charges & Borrowings of Unjha Formulations Limited

Open charges
₹32 Lakh
Satisfied charges
₹0
Breakdown by lending institutions
Dena Bank₹0.32 Cr
Latest charge details
DateLenderAmountStatus
01 Sep 2007 Dena Bank ₹32 Lakh Open

Total charge records: 1 View all charges

Employees and EPFO Compliance at Unjha Formulations Limited

Unjha Formulations Limited has a workforce of 12 employees as of Apr 08, 2024.

Employee count
12
Active EPFO establishments
1
Employee growth
-14.29%
Premium access

Employee and EPFO history for Unjha Formulations Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Unjha Formulations Limited

Premium access

GST registrations and filing compliance for Unjha Formulations Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Unjha Formulations Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Unjha Formulations Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Unjha Formulations Limited

Premium access

MSME payment history for Unjha Formulations Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Unjha Formulations Limited

Premium access

Corporate group structure for Unjha Formulations Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Unjha Formulations Limited

Premium access

MCA filings and documents for Unjha Formulations Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Unjha Formulations Limited

Directors
17 Jun 2026
Khushboo Niteshkumar Patel was appointed as a Company Secretary on 17 Jun 2026 & has been associated with this company since 1 month 2 days.
Activity
13 Aug 2025
Unjha Formulations Limited last Annual general meeting of members was held on 13 Aug 2025 as per latest MCA records.
Activity
31 Mar 2025
Unjha Formulations Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Directors
10 May 2023
Esha Mayank Patel was appointed as a Whole-time director on 10 May 2023 & has been associated with this company since 3 years 2 months.
Directors
06 Feb 2021
Mustufa Najmuddin Jodhpurwala was appointed as a Director on 06 Feb 2021 & has been associated with this company since 5 years 5 months.
Charges
27 Mar 2018
A charge with Dena Bank of Rs. 0.32 Cr registered on 01 Sep 2007 with Charge ID 10068093 was modified on 27 Mar 2018.

Recent News on Unjha Formulations Limited

Frequently Asked Questions about Unjha Formulations Limited

Unjha Formulations Limited is an active public limited company in the healthcare sector based in Khali, Gujarat, India. It was incorporated on 02 September 1994 (32+ years old) and is registered under CIN L99999GJ1994PLC022932. Listed on BSE: 531762. The company has 12 employees.

Unjha Formulations Limited reported revenue of ₹15.59 Cr for FY 2026 (up 12.43% YoY) based on standalone BSE filings.

The current directors of Unjha Formulations Limited are:

The primary industry of Unjha Formulations Limited is healthcare. The company specifically operates in ayurvedic products and services. The company is currently active in this sector.

Yes. Unjha Formulations Limited is listed on BSE with code 531762.

Unjha Formulations Limited can be reached at the registered office: Khali Char Rasta State Highway Tal – Sidhpur Patan, Gujarat, India – 384151, or through the website unjhaformulations.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available